INDICATIONS

SENOKOT Tablets/Granules and Double-Strength SenokotXTRA Tablets contain a natural vegetable derivative, standardized for uniform action. Each Double-Strength SenokotXTRA Tablet contains twice the active ingredient in one SENOKOT Tablet; patients may take one Double-Strength SenokotXTRA Tablet instead of two SENOKOT Tablets.

Senokot Laxatives provide a virtually colon-specific action which is gentle, effective and predictable, generally producing bowel movement in 6 to 12 hours. SENOKOT has been found to be effective even in many previously intractable cases of functional constipation. SENOKOT preparations may aid in rehabilitation of the constipated patient by facilitating regular elimination. At proper dosage levels, SENOKOT preparations are virtually free of adverse reactions (such as loose stools or abdominal discomfort) and enjoy high patient acceptance. Numerous and extensive clinical studies show their high degree of effectiveness in several types of functional constipation: geriatric and postpartum, drug-induced, pediatric, as well as in functional constipation concurrent with heart disease or anorectal surgery.

SENOKOT-S Tablets are designed to relieve both aspects of functional constipation--bowel inertia and hard, dry stools. They provide a natural neuroperistaltic stimulant combined with a classic stool softener, standardized senna concentrate gently stimulates the colon while docusate sodium softens the stool for smoother and easier evacuation. This coordinated dual action of the two ingredients results in colon-specific, predictable laxative effect, generally producing bowel movement in 6 to 12 hours. Flexibility of dosage permits fine adjustment to individual requirements. SENOKOT-S Tablets are highly suitable for relief of postsurgical and postpartum constipation, and effectively counter-act drug-induced constipation.

SENOKOT Tablets:  Each tablet contains 8.6 mg sennosides.

Active Ingredient: Standardized Senna Concentrate.

Inactive Ingredients: Corn starch, Glycerin, Lactose, Magnesium Stearate, Talc and other ingredients.

SENOKOT Granules:  (cocoa-flavored):  Each teaspoonful contains 15 mg sennosides.

Active Ingredient:  Standardized Senna Concentrate.

Inactive Ingredients: Cocoa, Malt extract, Sodium lauryl sulfate, Sucrose, Vanillin and other ingredients.

SenokotXTRA Tablets:  Each tablet contains 17 mg sennosides.

Active Ingredient:  Standardized Senna Concentrate.

Inactive Ingredients:  Corn Starch, Glycerin, Lactose, Magnesium stearate, Talc and other ingredients.

SENOKOT-S Tablets:  Each tablet contains 8.6 mg sennosides and 50 mg of docusate sodium. Active Ingredients: Docusate Sodium and Standardized Senna Concentrate.

Inactive Ingredients:  Cellulosic polymers, Corn starch, FD&C Yellow No. 10, FD&C Yellow No. 6 (Sunset Yellow), Guar Gum, Lactose, Polyethylene glycol, Talc, Titanium dioxide, and other ingredients.

RECOMMENDED DOSAGE

(or as directed by a doctor): Take preferably at bedtime.

For older, debilitated patients, the physician may consider prescribing 1 / 2 the initial dose.

Senokot Tablets and Granules are available for children under 6 years of age. For children under 2 years of age, consult a physician.

SENOKOT Tablets and SENOKOT-S Tablets:

Recommended Dosage (or as directed by a doctor):

Take preferably at bedtime.

AGE STARTING MAXIMUM
Adults and children
12 years of age
and over
2 tablets
once a day
4 tablets
twice a day
6 to under
12 years of age
1 tablet
once a day
2 tablets
twice a day
2 to under
6 years of age
1 / 2 tablet
once a day
1 tablet
twice a day
Under 2 years
Consult a physician.

Double-Strength SenokotXTRA Tablets:

Recommended Dosage (or as directed by a doctor): Take preferably at bedtime.

AGE STARTING MAXIMUM
Adults and
children 12 years
of age and over
1 tablet
once a day
2 tablets
twice a day
6 to under 12
years of age
1 / 2 tablet
once a day
1 tablet
twice a day

SENOKOT Granules (May be eaten plain, mixed with liquids such as milk to make a delicious drink, or sprinkled on foods.):

AGE STARTING MAXIMUM
Adults and
children 12 years
of age and over
1 teaspoon
once a day
2 teaspoons
twice a day
6 to under
12 years of age
1 / 2 teaspoon
once a day
1 teaspoon
twice a day
2 to under
6 years of age
1 / 4 teaspoon
once a day
1 / 2 teaspoon
twice a day
Under 2 years
Consult a physician.

Do not use laxative products when abdominal pain, nausea or vomiting are present unless directed by a doctor. If you have noticed a sudden change in bowel movements that persists over a period of 2 weeks, consult a doctor before using a laxative. Laxative products should not be used for a period longer than 1 week unless directed by a doctor. Rectal bleeding or failure to have a bowel movement after use of a laxative may indicate a serious condition. Discontinue use and consult your doctor. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health professional before using this product. In case of accidental overdose, seek professional assistance or contact a Poison Control Center immediately. Keep out of children's reach.

HOW SUPPLIED

Tablets:   Boxes of 20; bottles of 50, 100 and 1000. Unit Strip Packs in boxes of 100 tablets: each tablet individually sealed. Double-Strength SenokotXTRA Tablets: Boxes of 12 and 36.

Senokot-S Tablets are supplied in packages of 10, bottles of 30, 60, and 1000 tablets, and Unit Strip Boxes of 100 tablets.

Granules:  2, 6, and 12 oz. plastic containers.

ALSO AVAILABLE

SENOKOT Syrup (extract of senna concentrate) in bottles of 2 and 8 fl. oz. Each teaspoon of SENOKOT Syrup contains 8.8 mg sennosides.

Active Ingredient:  Extract of Senna Concentrate.

Inactive Ingredients:  Methylparaben, Potassium sorbate, Propylparaben, Sucrose, Water, Natural and artificial chocolate flavor and other ingredients.

Copyright 1991, 2000, The Purdue Frederick Company

Stamford, CT 06901-3431

PRODUCT PHOTO(S):

NOTE: These photos can be used only for identification by shape, color, and imprint. They do not depict actual or relative size.

The product samples shown here have been supplied by the manufacturer and reproduced in full color by PDR as a quick-reference identification aid. While every effort has been made to assure accurate reproduction, please remember that any visual identification should be considered preliminary. In cases of poisoning or suspected overdosage, the drug' identity should be verified by chemical analysis.

images/pills/n00518d3.jpg
images/pills/n00519a1.jpg